Caris Life Sciences, Inc. (CAI)
NASDAQ · Healthcare
Caris Life Sciences, Inc. Long Term Debt 2023–2025
Caris Life Sciences, Inc. annual/quarterly long term debt history from 2024 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Caris Life Sciences, Inc. long term debt for the quarter ending December 31, 2025 were 378.4M, a 1.42% increase year-over-year.
- Caris Life Sciences, Inc. long term debt for 2025 were 378.4M, a 1.42% increase from 2024.
- Caris Life Sciences, Inc. long term debt for 2024 were 373.1M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Caris Life Sciences, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $378 |
| 2024 | $373 |
| Caris Life Sciences, Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2025-12-31 | $378 |
| 2024-12-31 | $373 |
Caris Life Sciences, Inc. Long Term Debt — FAQ
Caris Life Sciences, Inc. (CAI) long term debt over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CAI's long term debt history?
The chart and table above show Caris Life Sciences, Inc.'s long term debt by year and by quarter, including the growth rate.